Patents by Inventor Silvia Lapenna

Silvia Lapenna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Steroidal ligands and their use in gene switch modulation
    Patent number: 9243263
    Abstract: The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: January 26, 2016
    Assignee: Intrexon Corporation
    Inventors: Robert E. Hormann, Silvia Lapenna, Laurence Neil Dinan
  • Steroidal Ligands and Their Use in Gene Switch Modulation
    Publication number: 20140057349
    Abstract: The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions.
    Type: Application
    Filed: July 22, 2013
    Publication date: February 27, 2014
    Applicant: Intrexon Corporation
    Inventors: Robert E. HORMANN, Silvia Lapenna, Laurence Neil Dinan
  • Steroidal ligands and their use in gene switch modulation
    Patent number: 8536354
    Abstract: The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: September 17, 2013
    Assignee: Intrexon Corporation
    Inventors: Robert E. Hormann, Silvia Lapenna, Laurence Neil Dinan
  • Steroidal Ligands and Their Use in Gene Switch Modulation
    Publication number: 20090298175
    Abstract: The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems. The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions.
    Type: Application
    Filed: March 16, 2009
    Publication date: December 3, 2009
    Inventors: Robert E. Hormann, Silvia Lapenna, Laurence Neil Dinan